In a recent interview, Mahsa Dolatshahi, M.D., M.P.H., and Cyrus A. Raji, M.D., Ph.D., discussed MRI and PET study findings, presented at the Radiological Society of North America (RSNA) conference, that showed an association between higher amyloid PET tracer uptake in the precuneus cortex and a higher visceral to subcutaneous fat ratio.

Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.

Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.

In a recent interview at the annual RSNA conference in Chicago, Richard Heller, MD discussed the impact of reduced reimbursement rates in radiology, the projected CMS conversion factor for 2024, the severity of payment cuts in interventional radiology and the importance of radiologist advocacy.

Dr. Kottler sat down with Diagnostic Imaging at RSNA 2023 to discuss AI imaging milestones and the potential impact of AI on workflows in radiology.

People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.

The Aquilion ONE/Insight Edition and Aquilion Serve SP computed tomography (CT) systems reportedly offer enhanced deep learning reconstruction and intuitive workflow efficiencies.

In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.

Catch up on the top radiology content of the past week.

Artificial intelligence (AI) assessments of chest X-rays identified 28 percent of a 17,000 plus cohort of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.

Through assessment of diffusion tensor MRI of the brain, a new AI system reportedly offers a 97 percent sensitivity rate in diagnosing autism in children between two to four years of age, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.

Utilizing computed tomography (CT) guidance, researchers have found that performing a minimally invasive anesthetic injection into the stellate ganglia may help address parosmia due to COVID-19, according to study results that will be presented at the annual Radiological Society of North America (RSNA) conference next week.

In a recent video interview, Ashesh Jani, M.D., discussed a subset analysis from the SPOTLIGHT trial that examined the utility of the PET PSMA agent flotufolastat F 18 (Posluma) for detecting prostate cancer recurrence in men with low PSA levels lower than 1 ng/mL.

In reportedly the first randomized study to compare hypofractionated radiation treatment versus conventional radiation treatment for women who had breast reconstruction procedures after mastectomy, researchers at the recent ASTRO conference noted similar rates of cancer recurrence, chest wall toxicity and patient well-being.

Researchers noted a 20.1 percent incidence of bone-only metastasis in a cohort of men with castration-resistant prostate cancer, according to findings from research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

The Pulmonary Embolism (PE) Triage and Notification (PETN) module with RapidAI’s RapidPE platform reportedly demonstrated over 90 percent sensitivity and specificity rates for detection of central PE on computed tomography (CT), according to multicenter study findings presented at the 9th Annual Pulmonary Embolism Symposium.

For cT1 renal masses < 4 cm and renal masses < 2 cm, the PET/CT agent 89Zr-DFO-girentuximab had respective sensitivity rates of approximately 85 percent and 96.7 percent for diagnosing clear cell renal cell carcinoma, according to research recently presented at the European Association of Nuclear Medicine (EANM) 2023 Congress.

Twice-a-day consumption of reconstituted grape powder provides significant long-term benefit in preserving cerebral metabolism for people with mild cognitive decline, according to research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

The PSMA PET agent 64Cu SAR-bisPSMA detected a higher number of prostate cancer lesions and had a significantly higher SUVmax and SUVmean than 68Ga PSMA-11 PET/CT, according to initial data from a prospective multisite study presented at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.

Featuring sector and linear arrays, the FDA-cleared Vscan Air SL ultrasound device reportedly enables cardiac and vascular assessments at the point of care.